Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Tuesday, September 12, 2017
AMRI announced Stephen Leonard has joined the company as senior vice president, head of global operations.
read more
Wednesday, January 09, 2013
AMRI announced today that Richard A. Saffee has been promoted to the newly created role of Vice President and General Manager of Large Scale Manufacturing, effective immediately. He will continue to report to Steven R. Hagen, Ph.D., Senior Vice ...
read more
AMRI announced today that Susan Collins has been promoted to Director of Business Development for North American Discovery Services, reporting to Christopher Conway, Vice President, Business Development. In this new role, Ms. Collins is responsible ...
read more
Tuesday, February 26, 2013
AMRI announced today that it has promoted Takeshi Yura, Ph.D., to Vice President of Discovery and Development Services, Asia. Dr. Yura will report directly to Thomas E. D’Ambra, Ph.D., Chairman, President and CEO.
read more
AMRI (NASDAQ: AMRI) today announced that it will be transitioning Discovery and Development Services (DDS) activities at its Syracuse, N.Y. site to other sites within AMRI and will cease operations in Syracuse by the end of June 2014. The actions ...
read more
AMRI has secured a seven-year contract from the National Institute of Allergy and Infectious Disease (NIAID), part of the National Institutes of Health (NIH).
read more
AMRI has announced that its Buffalo, N.Y. site has been selected to participate as a Dedicated Chemical Biology Consortium (CBC) Center for the Experimental Therapeutics (NExT) Program, centered at the Frederick National Laboratory for Cancer ...
read more
Tuesday, September 08, 2020
AMRI has signed a supply agreement with AstraZeneca to support the manufacture of AstraZeneca’s COVID-19 vaccine candidate AZD1222.
read more
Monday, February 11, 2013
AMRI announced today that it has signed an exclusive license agreement with Chai Therapeutics, LLC for the development of ALB 109564(a), AMRI’s novel tubulin inhibitor compound in late Phase I testing for the treatment of cancer. This agreement ...
read more
AMRI has signed a definitive agreement to acquire all outstanding shares of Prime European Therapeuticals S.p.A., also known as "Euticals", in a transaction valued at approximately $358 million (EUR 315 million), consisting of shares of AMRI common ...
read more
AMRI (NASDAQ: AMRI) today announced that it has signed a definitive agreement to acquire all of the outstanding membership interests of Oso Biopharmaceuticals Manufacturing, LLC (“OsoBio”) for $110 million in cash. OsoBio is recognized as a premier ...
read more
Friday, February 23, 2018
AMRI announced expansion of its industry-leading container closure integrity testing (CCIT) services into the European Union.
read more
AMRI has won renewal of a 10-year contract worth up to $39.5 million with the National Institutes of Health Blueprint Neurotherapeutics Network.
read more
Wednesday, September 05, 2018
The alliance will promote Metrion's electrophysiology and ion channel screening expertise to global pharmaceutical and biotechnology clients.
read more
SSCI has enhanced its solid state characterization and method development capabilities, through the addition of the Cobalt Light Systems TRS100 Transmission Raman Spectrometer.
read more